Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|June 17, 2011
Phosphoproteins and the dawn of functional phenotypingJ Bodo, E D Hsi
Cell Proliferation|May 29, 2007
Isothiocyanate E-4IB induces MAPK activation, delayed cell cycle transition and apoptosisJ Bodo, J Duraj, J Jakubikova, et al.
Neoplasma|December 15, 2006
Isothiocyanate iberin modulates phase II enzymes, posttranslational modification of histones and inhibits growth of Caco-2 cells by inducing apoptosisJ Jakubikova, Y Bao, J Bodo, et al.
Neoplasma|November 15, 2005
Enhanced sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to the combination of cisplatin and synthetic isothiocyanate ethyl 4-isothiocyanatobutanoateJ Bodo, J Chovancova, L Hunakova, et al.
Neoplasma|August 2, 2005
Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variantsJ Duraj, K Zazrivcova, J Bodo, et al.
Neoplasma|October 3, 2006
Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cellsJ Duraj, J Bodo, M Sulikova, et al.
Neoplasma|March 25, 2009
Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cellsJ Duraj, L Hunakova, J Bodo, et al.
Neoplasma|October 24, 2007
Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell linesL Hunakova, J Bodo, J Chovancova, et al.
British Journal of Cancer|October 25, 2006
Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterationsJ Bodo, L Hunakova, P Kvasnicka, et al.
Neoplasma|August 2, 2005
Tumor targeted gene therapy with plasmid expressing human tumor necrosis factor alpha in vitro and in vivoA Pastorakova, K Hlubinova, J Bodo, et al.
Pageof 2